4 结果
FIELD OF THE INVENTION
The present invention relates to the use of Z-butylidenephthalide (Z-BP), especially relates to the use of Z-BP in activating autoimmune system. The effect of treating cancers by administering to a subject Z-BP in combination with mononuclear cells is much better than
CROSS-REFERENCES TO RELATED APPLICATIONS
This application claims the benefit of Taiwan Patent Application No. 100100673, filed on Jan. 7, 2011 in the Taiwan Intellectual Property Office, the disclosure of which is incorporated herein in its entirety by reference.
FIELD
The present invention relates
CROSS-REFERENCES TO RELATED APPLICATIONS
Not applicable.
BACKGROUND OF THE INVENTION
Field of the Invention
The present invention relates to the uses of a pharmaceutical formulation, which comprises (Z)-butylidenephthalide, especially to the uses of the pharmaceutical formulation in treating
BACKGROUND OF THE INVENTION
n-Butylidenephthalide (Bdph) is a chemical compound isolated from Angelica sinensis. It can be used to treat various tumors, e.g., gliobastoma multiforme and breast cancer. See, e.g., Tsai et al., Clin. Cancer Res. 2005, 11(9): 3475-3484 and Tsai, et al., J Neurochem.